EURONED-MS. Multiple Sclerosis in the Netherlands. A prospective inception cohort study.

Recruiting

• Conditions: MS; multiple sclerosis; 10007951

• Registration Number: NL-OMON41541
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 300

Inclusion Criteria

Patients are eligible when they are diagnosed within the previous twelve months with MS (Polman et al., 2011), with dissemination in time and space (see protocol Appendix 3). Patients with Clinically Isolated Syndromes (CIS) may also be included if they fulfill 3 of the 4 Barkhof criteria for dissemination in space as per application of the revised McDonald criteria (Polman et al. 2011). Patients should be 18 years or older, and live in the Netherlands, and give written informed consent.

Exclusion Criteria

not able to speak dutch, refusal to give informed consent

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Clinical and psychosocial data of all patients will be collected longitudinally<br /><br>and prospectively on a regular basis.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>